Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view - PubMed (original) (raw)
Review
Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view
Alan K Burnett. Br J Haematol. 2002 Aug.
Free article
No abstract available
Similar articles
- Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view.
Creutzig U, Reinhardt D. Creutzig U, et al. Br J Haematol. 2002 Aug;118(2):365-77. doi: 10.1046/j.1365-2141.2002.03697.x. Br J Haematol. 2002. PMID: 12139720 Review. No abstract available. - Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a statistician's view.
Wheatley K. Wheatley K. Br J Haematol. 2002 Aug;118(2):351-6. doi: 10.1046/j.1365-2141.2002.03696.x. Br J Haematol. 2002. PMID: 12139718 Review. No abstract available. - Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an American view.
Chen AR, Alonzo TA, Woods WG, Arceci RJ. Chen AR, et al. Br J Haematol. 2002 Aug;118(2):378-84. doi: 10.1046/j.1365-2141.2002.03701.x. Br J Haematol. 2002. PMID: 12139721 Review. No abstract available. - The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Bacigalupo A, Vitale V, Corvò R, Barra S, Lamparelli T, Gualandi F, Mordini N, Berisso G, Bregante S, Raiola AM, Van Lint MT, Frassoni F. Bacigalupo A, et al. Br J Haematol. 2000 Jan;108(1):99-104. doi: 10.1046/j.1365-2141.2000.01809.x. Br J Haematol. 2000. PMID: 10651732 - Allogeneic bone marrow transplantation for relapsed acute myeloid leukaemia (AML).
Grigg A, Bardy P, Szer J. Grigg A, et al. Aust N Z J Med. 1996 Aug;26(4):570-1. doi: 10.1111/j.1445-5994.1996.tb00613.x. Aust N Z J Med. 1996. PMID: 8873950 No abstract available.
Cited by
- MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.
Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. Garzon R, et al. Blood. 2008 Mar 15;111(6):3183-9. doi: 10.1182/blood-2007-07-098749. Epub 2008 Jan 10. Blood. 2008. PMID: 18187662 Free PMC article. - Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S, Lin F, Yonghui L, Li Y, Weidong W. Jinlong S, et al. PLoS One. 2015 Feb 3;10(2):e0118099. doi: 10.1371/journal.pone.0118099. eCollection 2015. PLoS One. 2015. PMID: 25646775 Free PMC article. - Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
Buyse M, Squifflet P, Lange BJ, Alonzo TA, Larson RA, Kolitz JE, George SL, Bloomfield CD, Castaigne S, Chevret S, Blaise D, Maraninchi D, Lucchesi KJ, Burzykowski T. Buyse M, et al. Blood. 2011 Jun 30;117(26):7007-13. doi: 10.1182/blood-2011-02-337725. Epub 2011 Apr 25. Blood. 2011. PMID: 21518931 Free PMC article. - Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B. Garzon R, et al. Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50. doi: 10.1073/pnas.0800135105. Epub 2008 Feb 28. Proc Natl Acad Sci U S A. 2008. PMID: 18308931 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical